Yes, Evelina London has many global research partnerships in place that are delivering breakthroughs in children's treatment and care.
Evelina London is part of Guy's and St Thomas', who already works very closely with King's College London (KCL), one of the top universities in the world for medical research, and has active research partnerships with the Institute of Cancer Research (ICR). Together with KCL, we have developed and delivered the type of cutting-edge therapies and clinical interventions that will be crucial to the future of children's cancer care.
This includes pioneering imaging studies that have advanced understanding of brain and heart function, ground-breaking clinical trials into peanut allergies, and we're carrying out the first ever clinical trial of a new class of cancer treating immunotherapy, IgE.
We have 2 dedicated research wards with the ability to deliver the earliest phase of clinical trials, so we can immediately begin new children's cancer clinical research studies and offer the latest immune therapies like CAR-T. When reviewing the 2 options for the new children’s cancer centre, NHS England independently assessed Evelina London as having the best potential for enhancing children's cancer research.